These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

922 related items for PubMed ID: 17139617

  • 1. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY, Kim BH, Choi M, Yoo EJ, Moon KC, Cho YM, Kim D, Kang GH.
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [Abstract] [Full Text] [Related]

  • 2. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH, Lee S, Lee HJ, Hwang KS.
    J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
    Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Müller SC, von Ruecker A.
    Clin Cancer Res; 2005 Jun 01; 11(11):4097-106. PubMed ID: 15930345
    [Abstract] [Full Text] [Related]

  • 4. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.
    Ellinger J, Bastian PJ, Jurgan T, Biermann K, Kahl P, Heukamp LC, Wernert N, Müller SC, von Ruecker A.
    Urology; 2008 Jan 01; 71(1):161-7. PubMed ID: 18242387
    [Abstract] [Full Text] [Related]

  • 5. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
    Bastian PJ, Palapattu GS, Lin X, Yegnasubramanian S, Mangold LA, Trock B, Eisenberger MA, Partin AW, Nelson WG.
    Clin Cancer Res; 2005 Jun 01; 11(11):4037-43. PubMed ID: 15930338
    [Abstract] [Full Text] [Related]

  • 6. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
    Lee HS, Kim BH, Cho NY, Yoo EJ, Choi M, Shin SH, Jang JJ, Suh KS, Kim YS, Kang GH.
    Clin Cancer Res; 2009 Feb 01; 15(3):812-20. PubMed ID: 19188151
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy.
    Bastian PJ, Ellinger J, Heukamp LC, Kahl P, Müller SC, von Rücker A.
    Eur Urol; 2007 Mar 01; 51(3):665-74; discussion 674. PubMed ID: 16956712
    [Abstract] [Full Text] [Related]

  • 8. A quantitative promoter methylation profile of prostate cancer.
    Jerónimo C, Henrique R, Hoque MO, Mambo E, Ribeiro FR, Varzim G, Oliveira J, Teixeira MR, Lopes C, Sidransky D.
    Clin Cancer Res; 2004 Dec 15; 10(24):8472-8. PubMed ID: 15623627
    [Abstract] [Full Text] [Related]

  • 9. Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection.
    Park SY, Yoo EJ, Cho NY, Kim N, Kang GH.
    J Pathol; 2009 Dec 15; 219(4):410-6. PubMed ID: 19639607
    [Abstract] [Full Text] [Related]

  • 10. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J, Haan K, Heukamp LC, Kahl P, Büttner R, Müller SC, von Ruecker A, Bastian PJ.
    Prostate; 2008 Jan 01; 68(1):42-9. PubMed ID: 18004747
    [Abstract] [Full Text] [Related]

  • 11. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.
    Nakayama M, Gonzalgo ML, Yegnasubramanian S, Lin X, De Marzo AM, Nelson WG.
    J Cell Biochem; 2004 Feb 15; 91(3):540-52. PubMed ID: 14755684
    [Abstract] [Full Text] [Related]

  • 12. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS.
    Prostaglandins Other Lipid Mediat; 2007 Jan 15; 82(1-4):185-97. PubMed ID: 17164146
    [Abstract] [Full Text] [Related]

  • 13. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells.
    Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ.
    Oncogene; 2002 Feb 07; 21(7):1048-61. PubMed ID: 11850822
    [Abstract] [Full Text] [Related]

  • 14. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
    Singal R, Ferdinand L, Reis IM, Schlesselman JJ.
    Oncol Rep; 2004 Sep 07; 12(3):631-7. PubMed ID: 15289848
    [Abstract] [Full Text] [Related]

  • 15. Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma.
    Enokida H, Shiina H, Urakami S, Terashima M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Igawa M, Dahiya R.
    Cancer; 2006 Jan 01; 106(1):79-86. PubMed ID: 16323173
    [Abstract] [Full Text] [Related]

  • 16. Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
    Lou W, Krill D, Dhir R, Becich MJ, Dong JT, Frierson HF, Isaacs WB, Isaacs JT, Gao AC.
    Cancer Res; 1999 May 15; 59(10):2329-31. PubMed ID: 10344738
    [Abstract] [Full Text] [Related]

  • 17. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
    Lin X, Asgari K, Putzi MJ, Gage WR, Yu X, Cornblatt BS, Kumar A, Piantadosi S, DeWeese TL, De Marzo AM, Nelson WG.
    Cancer Res; 2001 Dec 15; 61(24):8611-6. PubMed ID: 11751372
    [Abstract] [Full Text] [Related]

  • 18. Differential repetitive DNA methylation in multiple myeloma molecular subgroups.
    Bollati V, Fabris S, Pegoraro V, Ronchetti D, Mosca L, Deliliers GL, Motta V, Bertazzi PA, Baccarelli A, Neri A.
    Carcinogenesis; 2009 Aug 15; 30(8):1330-5. PubMed ID: 19531770
    [Abstract] [Full Text] [Related]

  • 19. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ, Ellinger J, Schmidt D, Wernert N, Wellmann A, Müller SC, von Rücker A.
    Eur J Med Res; 2004 Nov 29; 9(11):523-7. PubMed ID: 15649863
    [Abstract] [Full Text] [Related]

  • 20. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
    Enokida H, Shiina H, Igawa M, Ogishima T, Kawakami T, Bassett WW, Anast JW, Li LC, Urakami S, Terashima M, Verma M, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R.
    Cancer Res; 2004 Sep 01; 64(17):5956-62. PubMed ID: 15342374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.